GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon Pharma Indonesia PT (ISX:SCPI) » Definitions » Change In Payables And Accrued Expense

Organon Pharma Indonesia PT (ISX:SCPI) Change In Payables And Accrued Expense : Rp0.00 Mil (TTM As of . 20)


View and export this data going back to 1990. Start your Free Trial

What is Organon Pharma Indonesia PT Change In Payables And Accrued Expense?

Organon Pharma Indonesia PT's Change In Payables And Accrued Expense for the quarter that ended in . 20 was Rp0.00 Mil. It means Organon Pharma Indonesia PT's Accounts Payable & Accrued Expense stayed the same from . 20 to . 20 .

Organon Pharma Indonesia PT's Change In Payables And Accrued Expense for the fiscal year that ended in . 20 was Rp0.00 Mil. It means Organon Pharma Indonesia PT's Accounts Payable & Accrued Expense stayed the same from . 20 to . 20 .


Organon Pharma Indonesia PT Change In Payables And Accrued Expense Historical Data

The historical data trend for Organon Pharma Indonesia PT's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organon Pharma Indonesia PT Change In Payables And Accrued Expense Chart

Organon Pharma Indonesia PT Annual Data
Trend
Change In Payables And Accrued Expense

Organon Pharma Indonesia PT Quarterly Data
Change In Payables And Accrued Expense

Organon Pharma Indonesia PT Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in . 20 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Organon Pharma Indonesia PT Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Organon Pharma Indonesia PT's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Organon Pharma Indonesia PT (ISX:SCPI) Business Description

Traded in Other Exchanges
N/A
Address
Jalan Jend Sudirman Kav 21, Sinarmas MSIG Tower, Floor 37 Unit 102 & 106, South Jakarta, IDN, 12920
Organon Pharma Indonesia PT engages in the development, manufacture, and distribution of pharmaceutical products. It operates through manufacturing and commercial segments. Manufacturing, which generates the majority of the revenue, is engaged in pharmaceutical manufacturing.

Organon Pharma Indonesia PT (ISX:SCPI) Headlines

No Headlines